PTC
CLBT icon

Private Trust Company’s Cellebrite CLBT Stock Holding History

Private Trust Company’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-242
Closed -$3.87K – 2574
2025
Q2 		$3.87K Buy
242
+81
+50% +$1.44K ﹤0.01% 2141
2025
Q1 		$3.13K Buy
161
+68
+73% +$1.43K ﹤0.01% 2182
2024
Q4 		$2.05K Buy
+93
New +$1.79K ﹤0.01% 2165

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Private Trust Company's CLBT Position: Q3 2025 in Review

Private Trust Company sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 242 shares — an estimated $3.87K sold.

Private Trust Company first reported a position in CLBT in Q4 2024 and held it in 3 quarters. The position peaked at $3.87K in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Private Trust Company reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Private Trust Company sold 242 Cellebrite shares in Q3 2025, an estimated $3.87K.
  • Private Trust Company first reported a position in Cellebrite in Q4 2024 and held it in 3 quarters.
  • Private Trust Company's Cellebrite position peaked at $3.87K in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Private Trust Company's 13F filing for Q3 2025, filed 15 Oct 2025.